| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8460487 | Annals of Anatomy - Anatomischer Anzeiger | 2017 | 16 Pages |
Abstract
Our results reveal that aflibercept significantly lowers the amount of unbound VEGF as well as the proliferation rate of HUVEC. Moreover, in contrast to specifications given by the manufacturer, aflibercept retains its full inhibitory effect up to at least 120Â h after transference from the original vial into the injection syringe.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
M. Schicht, K. Hesse, H. Schröder, E. Naschberger, W. Lamprecht, F. Garreis, F.P. Paulsen, L. Bräuer,